March 29, 2019

Precision Biosciences, the gene-editing startup, started trading on the Nasdaq stock exchange today after raising a $126.4 million IPO, valuing the company at $870 million.

The IPO will achieve an exit for growth stage agrifood tech investor Pontifax AgTech, which inves...

September 12, 2018

FOSTER CITY, Calif. & DURHAM, N.C.--(BUSINESS WIRE)--Gilead Sciences (Nasdaq: GILD) and Precision BioSciences announced today that the companies have entered into a strategic collaboration to develop therapies targeting the in vivo elimination of hepatitis B virus (HBV...

Please reload

Recent Posts
Please reload

Archive
Please reload

2025 S Westgate Ave, First Floor, Los Angeles, CA 90025

info@pontifaxagtech.com  |  323-306-9970 

© 2014 Pontifax Global Food and Agriculture Technology Fund LP

  • LinkedIn Social Icon